Given the success of immune checkpoint inhibitors and chimeric antigen receptor (CAR) T cells in clinical settings, the host immune system plays an important role in the recognition and targeting of tumor cell...
from Most Recent Articles: Journal of Hematology & Oncology http://bit.ly/2KoAvHE
via IFTTT
No comments:
Post a Comment